CDMO Profile

Kaneka Eurogentec

Kaneka Eurogentec Contract Manufacturing & Development (CDMO) Profile

FDA inspected multimodality CRDMO for small molecules, biologics and cell and gene therapy products. Custom drug substance manufacturing of oligonucleotides, peptides, mRNA , plasmid DNA, recombinant proteins for human clinical and commercial use.

CDMO Services:
Small Molecule; Biologics; Cell & Gene Therapy Drug Substance Manufacturing (API); Research & Development

Year Founded: 1985

Head Office: Seraing, Belgium

Number of Facilities: 3-5

Facility locations: Europe; North America

Website: Visit the Kaneka Eurogentec website

Linkedin: Connect on Linkedin

Current Capacity: Capacity available for all modalities

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing. Register here

SURVEY

Benchmark your Outsourcing Strategies for 2025

DOWNLOAD

5 Digital Strategies for Decentralised Clinical Trials

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.